In-vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is one of the widely popular treatments, which has assisted couples with infertility problems, single mothers and the LGBT community to procreate. The global IVF devices market would witness a substantial growth in future owing to rising incidence of infertility cases, emerging trend of delayed pregnancies among women, technological advancements in IVF procedures and increased occurrences of gamete donations. Furthermore, rising health awareness on fertility issues, availability of IVF treatments, increasing disposable income and favorable reimbursement policies would further augment the market growth. Recent innovations in IVF technology, such as Embryoscope and capsule IVF, are anticipated to augment the demand of IVF devices in future. However, strenuous maintenance issues, high cost of devices, multiple pregnancies and ethical considerations are likely to hinder the market growth. Increasing upsurge of fertility clinics and same sex marriages would offer lucrative growth opportunities in future. In addition, fertility tourism would provide ample growth opportunities especially in the developing economies. The global IVF devices and consumables market accounted for $1,252.8 million in 2014 and is forecast to garner $3,627.2 million by 2020, registering a promising CAGR of 19.2% during the forecast period.
The global IVF devices market comprises five key segments namely, IVF instruments, reagents and media, technology, end users and geography. The instruments market considered in this report include, sperm separation system, cryosystem, incubator, imaging system, disposables and consumables ovum aspiration pump, IVF cabinet, micromanipulator, IVF accessories and disposables, and others. In the instruments market, micromanipulator is the highest revenue-generating segment owing to its extensive use in various stages of the IVF procedure. However, sperm separation system segment would witness a significant growth due to its extensive use in healthy sperm selection and gender determination.
Based on reagents and media, the global IVF devices market is categorized into cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue-generating segment due to its extensive use in frozen IVF cycles. IVF devices and consumables market by techniques is categorized into fresh embryo transfer technique, frozen egg transfer technique and donor egg transfer technique. In the current market scenario, fresh embryo transfer technique is the highest revenue-generating segment and would continue to maintain this trend during the forecast period owing to the higher user preference for this technique.
The global IVF devices market by end-users is segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. Fertility clinics is the highest revenue-generating segment in the IVF market due to easy accessibility of IVF treatment and services and high success rates. Furthermore, surgical centers is forecast to exhibit rapid growth due to the use of sophisticated IVF technologies.
The global IVF devices market has been analyzed on the basis of geographical regions, which include North America, Europe, Asia Pacific and LAMEA. Europe and North America are the dominant regions of this market, collectively accounting for about 79% of the total market share. This is mainly attributed to the widespread adoption of advanced technologies, healthcare awareness, favorable reimbursement policies and supportive legal frameworks. Nevertheless, Asia Pacific would emerge as the fastest growing region owing to low manufacturing costs of IVF devices and increasing popularity of medical tourism. Moreover, availability of skilled personnel and rising awareness would further augment the market growth in this region.
The competitive landscape of the IVF devices market indicates the presence of local as well as global IVF device manufacturers. Product launch has been the prime growth strategy adopted by the major market players to improve their market share. Some of the prominent product launches include micromanipulators systems, ovum aspiration pumps and IVF accessories. These technologies are used in both clinical and research fields. The key companies profiled in this report include, Vitrolife AB, EMD Serono, Inc., Irvine Scientific, Cooper Surgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology and OvaScience, Inc.
1.1 KEY MARKET BENEFITS
An in-depth analysis of the current research and clinical developments in the global IVF devices market has been provided with key factors to understand the market scenario.
The projections in the report are based on the analysis of the current market trends and future market potential in terms of value during the period of 2014–2020.
An exhaustive analysis of the global IVF devices market by instruments helps in understanding the type of devices that are currently being used along with the variants that would gain prominence in future.
Competitive intelligence of leading manufacturers and distributors of IVF devices highlights the business practices followed by leading market players across various geographies.
SWOT analysis facilitates the study of the internal environment of prominent companies for strategy formulation.
A comprehensive analysis of the market has been conducted by closely monitoring key products of top contenders in the market.
1.2 KEY MARKET SEGMENTS
The global IVF devices market is segmented on the basis of instruments, reagents and media, techniques, end users and geography.
Global IVF Devices Market - By Instruments
Ovum aspiration pump
Sperm separation system
Accessories and disposables
Global IVF Devices Market - By Reagents and Media
Semen processing media
Ovum processing media
Embryo culture media
Global IVF Devices Market - By Technology
Fresh embryo transfer technique
Frozen embryo transfer technique
Donor egg IVF technique
Global IVF Devices Market - By End Users
Clinical research institutes
Global IVF Devices Market - By Geography
CHAPTER 1 INTRODUCTION
1.1 Report Description 1.2 KEY MARKET BENEFITS 1.3 KEY MARKET SEGMENTS 1.1 Research methodology 1.1.1 Secondary research 1.1.2 Primary research 1.1.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF DEVICES AND CONSUMABLES MARKET OVERVIEW
3.1 Market definition and scope 3.2 Alternative Technologies 3.2.1 Intrauterine Insemination (IUI) Technique 18.104.22.168 Factors assessed for the procedure 22.214.171.124 Benefits of this technique 126.96.36.199 Risks 3.2.2 Difference between IUI and IVF technique 3.2.3 GIFT technique 188.8.131.52 Difference between GIFT and IVF technique 3.2.4 ZIFT technique 184.108.40.206 Differences between ZIFT and IVF technique 3.3 Replacing IVF procedures by fertility drugs and surgeries 3.3.1 Female infertility treatments 220.127.116.11 Limitations of fertility drugs 3.3.2 Male infertility treatments 3.4 Costs related to IVF procedures 3.5 Role of donors in the IVF market 3.5.1 Egg donation 3.5.2 Egg sharing 3.5.3 Sperm donation 3.5.4 Embryo donation/adoption 3.5.5 Donation for research 3.6 Surrogacy 3.6.1 Legal issues 3.7 IVF trends in same sex couples 3.7.1 Artificial insemination 3.7.2 Surrogate mothers 3.7.3 In-vitro fertilization 3.8 Advanced IVF technologies 3.8.1 Capsule IVF 3.8.2 Three parent IVF 18.104.22.168 Ethical concerns 3.8.3 Mini IVF 22.214.171.124 Advantages 126.96.36.199 Drawbacks 3.8.4 EmbryoScope 188.8.131.52 Advantages 3.8.5 PICSI 3.9 Fertility treatment and Gender selection 3.9.1 Methods of sex selection 184.108.40.206 Gradient method 220.127.116.11 Flow cytometry technique 18.104.22.168 Pre-implantation genetic diagnosis (PGD) 22.214.171.124 Ethical and legal issues 3.10 Metabolomics in embryo screening methods 3.11 Application of stem cells in IVF 3.12 IVF and resource poor countries 3.13 Key Findings 3.13.1 Top factors impacting 3.13.2 Top investment pockets 3.13.3 Top winning strategies 3.14 Porters five forces analysis 3.14.1 High competition and large number reduces the power of suppliers 3.14.2 Scattered nature and large count of end users moderates the buyer power 3.14.3 High capital cost lowers the threat of new entrants 3.14.4 Industry rivalry is intense due to presence of few dominant competitors 3.14.5 Lack of efficient substitutes lowers the threat from substitutes 3.15 Value chain analysis 3.16 Patent Analysis 3.16.1 Patent analysis by type of patents 3.16.2 Patents Analysis by geography 3.17 Regulatory issues and legislations 3.18 Insurance reimbursement scenario 3.19 Clinical trials 3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF 3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome 3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation 3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment 3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures 3.20 Drivers 3.20.1 Delayed pregnancies in women 3.20.2 Rise in global infertility rates 3.20.3 Advancement in technology 3.20.4 Rise in gamete donations 3.20.5 Rise in disposable income 3.20.6 Increase in success rates 3.21 Restraints 3.21.1 Cost constraints 3.21.2 Ethical and legal issues 3.21.3 Multiple pregnancies 3.21.4 Low awareness level 3.22 Opportunities 3.22.1 Fertility tourism 3.22.2 Growing number of fertility clinics 3.22.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF DEVICES MARKET BY INSTRUMENTS
4.1 Global IVF market by instruments types, 2014-2020, ($million) 4.1.1 Incubators 126.96.36.199 Global IVF incubators market by geography 4.1.2 Cryosystem 188.8.131.52 Global IVF cryosystem market by geography 4.1.3 Imaging system 184.108.40.206 Global IVF Imaging system market by geography 4.1.4 Cabinet (work station) 220.127.116.11 Global IVF cabinets market by geography 4.1.5 Ovum aspiration pump 18.104.22.168 Global IVF ovum aspiration pump market by geography 4.1.6 Sperm separation system 22.214.171.124 Global IVF Sperm separation system market by geography 4.1.7 Micro Manipulator System 126.96.36.199 Global IVF Micromanipulator market by geography 4.1.8 Others 188.8.131.52 Global IVF other instruments market by geography 4.2 Accessories and disposables 4.2.1 Semen analysis chamber 4.2.2 Plastic ware 4.2.3 Oocyte retrieval needles 4.2.4 Miscellaneous disposables 4.2.5 Global IVF accessories and disposables market by geography
CHAPTER 5 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA
5.1 Global IVF market by reagents and media types, 2014-2020, ($million) 5.2 Cryopreservation media 5.2.1 Embryo cryopreservation media 5.2.2 Sperm cryopreservation media 5.2.3 Oocyte cryopreservation media 5.2.4 Global IVF cryopreservation media market by geography 5.3 Semen processing media 5.3.1 Global IVF semen processing media market by geography 5.4 Ovum processing media 5.4.1 Global IVF ovum processing media market by geography 5.5 Embryo culture media 5.5.1 Global IVF embryo culture media market by geography
CHAPTER 6 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE
6.1 Global IVF market, by technique, 2014-2020 ($Million) 6.2 Fresh Embryo transfer technique 6.2.1 Drivers 184.108.40.206 trends of Delayed pregnancies 220.127.116.11 Growing rates of infertility 6.2.2 Restraints 18.104.22.168 Cost involved in the treatment 22.214.171.124 reimbursements issues with fresh embryo ivf cycles 6.2.3 Global fresh embryo IVF cycle market, by geography 6.3 Frozen embryo transfer technique (FER) 6.3.1 Reasons to use this technique 6.3.2 Advantages of Frozen egg IVF technique 6.3.3 Disadvantages of frozen egg IVF technique 6.3.4 Global frozen egg IVF cycle market, by geography 6.4 Donor Egg IVF technique 6.4.1 Benefits of donor egg IVF technique 6.4.2 Risks associated with donor egg IVF cycle technique 6.4.3 Global donor egg IVF cycle market by geography
CHAPTER 7 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS
7.1 Global IVF market by end users, 2014-2020 ($Million) 7.2 Hospitals 7.2.1 Global IVF hospitals enduser market by geography 7.3 Surgical centers 7.3.1 Global IVF surgical centers enduser market by geography 7.4 Clinical research institutes 7.4.1 Global IVF clinical research institutes enduser market by geography 7.5 Clinics 7.5.1 Global IVF Clinics endusers market by geography
CHAPTER 8 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY
8.1 North America 8.1.1 North America IVF Devices and Consumables Market, By components 126.96.36.199 United States IVF devices and consumables market 188.8.131.52 Canada IVF devices and consumables market 184.108.40.206 Mexico IVF devices and consumables market 8.2 Europe 8.2.1 Europe IVF Devices and Consumables Market, By Component 220.127.116.11 Germany IVF devices and consumables market 18.104.22.168 France IVF devices and consumables market 22.214.171.124 United Kingdom IVF devices and consumables market 126.96.36.199 Other Europe IVF devices and consumables market 8.3 Asia-Pacific 8.3.1 Asia-Pacific IVF Devices and Consumables Market, By Component 188.8.131.52 India IVF devices and consumables market 184.108.40.206 China IVF devices and consumables market 220.127.116.11 Japan IVF devices and consumables market 18.104.22.168 Australia IVF devices and consumables market 22.214.171.124 other asia-pacific IVF devices and consumables market 8.4 LAMEA 8.4.1 LAMEA IVF Devices and Consumables Market, By Component 126.96.36.199 Latin America IVF devices and consumables market 188.8.131.52 Middle East IVF devices and consumables market 184.108.40.206 Africa IVF devices and consumables market
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB 9.1.1 Company overview 9.1.2 Business performance 9.1.3 Strategic moves and developments 9.1.4 SWOT Analysis of Vitrolife AB 9.2 EMD Serono, Inc. 9.2.1 Company overview 9.2.2 Business performance 9.2.3 Strategic moves and developments 9.2.4 SWOT Analysis of EMD Serono, Inc. 9.3 Irvine Scientific 9.3.1 Company overview 9.3.2 Business performance 9.3.3 Strategic moves and developments 9.3.4 SWOT Analysis of Irvine scientific 9.4 Cooper Surgical, Inc. (Origio) 9.4.1 Company overview 9.4.2 Business performance 9.4.3 Strategic moves and developments 9.4.4 SWOT Analysis of Cooper Surgical, Inc. 9.5 Cook Medical, Inc. 9.5.1 Company overview 9.5.2 Strategic moves and developments 9.5.3 SWOT Analysis of Cook medical, Inc. 9.6 Thermo Fisher Scientific Inc. 9.6.1 Company overview: 9.6.2 Business Performance 9.6.3 Strategic moves and developments 9.6.4 SWOT Analysis of Thermo Fisher Scientific, Inc. 9.7 Genea Biomedx 9.7.1 Company overview 9.7.2 Strategic moves and developments 9.7.3 SWOT Analysis of Genea Biomedx 9.8 Auxogyn, Inc. 9.8.1 Company overview 9.8.2 Strategic moves and developments 220.127.116.11 Primary strategies 18.104.22.168 Other strategies 9.8.3 SWOT Analysis of Auxogyn, Inc. 9.9 Oxford Gene Technology 9.9.1 Company overview 9.9.2 Strategic moves and developments 9.9.3 SWOT analysis of Oxford Gene Technology 9.10 Ovascience Inc. 9.10.1 Company overview 9.10.2 Business Performance 9.10.3 Strategic moves and developments 9.10.4 SWOT analysis of OvaScience, Inc.
List of Figures
FIG. 1 IVF DEVICES MARKET DEFINITION FIG. 2 ASIA-PACIFIC ADOPTION RATE BY TYPE OF SURROGACY FIG. 3 TOP IMPACTIG FACTORS (2014-2020) FIG. 4 TOP INVESTMENT POCKETS OF GLOBAL IVF DEVICES MARKET (2014-2020) FIG. 5 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET 20122015 FIG. 6 TOP WINNING STRATEGIES IN GLOBAL IVF DEVICES MARKET, 2012-2015 FIG. 7 PORTERS FIVE FORCE ANALYSIS FIG. 8 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET FIG. 9 PATENT ANALYSIS BY TYPE OF PATENTS (2011-2015) FIG. 10 PATENT ANALYSIS BY GEOGRAPHY (2011-2015) FIG. 11 EFFECT OF AGE ON FERTILITY FIG. 12 COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE FIG. 13 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE, 2013, U.S. FIG. 14 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2013 (U.S.) FIG. 15 VITROLIFE AB, SALES PER REGION, 2014 FIG. 16 VITROLIFE AB, REVENUES ($MILLION), 2012-2014 FIG. 17 SWOT ANALYSIS OF VITROLIFE AB FIG. 18 EMD SERONO SALES BY REGION, 2012 FIG. 19 SWOT ANALYSIS OF EMD SERONO, INC. FIG. 20 SWOT ANALYSIS OF IRVINE SCIENTIFIC FIG. 21 SWOT ANALYSIS OF COOPER SURGICAL, INC. FIG. 22 SWOT ANALYSIS OF COOK MEDICAL, INC. FIG. 23 THERMO FISHER SCIENTIFIC, INC. FINANCIAL REVENUES BY BUSINESS UNITS (2013) FIG. 24 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2013) FIG. 25 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC, INC. FIG. 26 SWOT ANALYSIS OF GENEA BIOMEDX FIG. 27 SWOT ANALYSIS OF AUXOGYN, INC. FIG. 28 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY FIG. 29 SWOT ANALYSIS OF OVASCIENCE, INC.
List of Tables
TABLE 1 COMPARISON BETWEEN IUI AND IVF PROCEDURES TABLE 2 COMPARISON BETWEEN GIFT AND IVF TECHNOLOGY TABLE 3 COMPARISON BETWEEN ZIFT AND IVF TECHNOLOGY TABLE 4 COST OF DONOR EGG PROCEDURE IN UNITED STATES (2014) TABLE 5 COST OF SPERM DONATION (2014) TABLE 6 AVERAGE SURROGACY COSTS, 2014 TABLE 7 COMPARISON BETWEEN TRADITIONAL AND GESTATIONAL SURROGACY TABLE 8 COMPARISON BETWEEN MINI IVF AND CONVENTIONAL IVF TECHNOLOGY TABLE 9 APPLICATIONS OF PGD TECHNOLOGY TABLE 10 PRODUCT LAUNCH AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015 TABLE 11 AGREEMENT AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 20122015 TABLE 12 COLLABORATION AS A GROWTH STRATEGY BY THE KEY MARKET PLAYERS IN GLOBAL IVF DEVICES MARKET, 2012-2015 TABLE 13 INSURANCE COVERAGE FOR COUNTRIES TABLE 14 INFERTILITY RATES IN NORTH AMERICA TABLE 15 GLOBAL DISPOSABLE INCOME, 2014-2021 TABLE 16 IVF SUCCESS RATES BY AGE, EUROPE TABLE 17 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY INSTRUMENTS TYPES, 2014-2020 ($MILLION) TABLE 18 TECHNOLOGICAL VARIABLES FOR COMMERCIAL IVF INCUBATORS TABLE 19 GLOBAL IVF INCUBATORS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 20 GLOBAL IVF CRYOSYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 21 GLOBAL IVF IMAGING SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 22 GLOBAL IVF CABINETS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 23 GLOBAL IVF OVUM APIRATION PUMP MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 24 MOTILITY OF SPERMS RETRIEVED THROUGH SPERM SEPARATION SYSTEM TABLE 25 GLOBAL IVF SPERM SEPARATION SYSTEM MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 26 GLOBAL IVF MICROMANIPULATOR MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 27 GLOBAL IVF OTHER INSTRUMENTS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 28 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 29 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY REAGENTS AND MEDIA TYPES, 2014-2020 ($MILLION) TABLE 30 ADVANTAGES AND DISADVANTAGES OF CRYOPRESERVATION PROCEDURES TABLE 31 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES TABLE 32 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 33 COMMERCIALLY AVAILABLE SPERM PROCESSING MEDIA IN THE MARKET TABLE 34 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 35 GLOBAL IVF OVUM PROCESSING MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 36 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES TABLE 37 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 38 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY TECHNIQUE, 2014-2020 ($MILLION) TABLE 39 GLOBAL FRESH EMBRYO IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 40 COMPARISON BETWEEN FRESH AND FROZEN EMBRYO TRANSFER PROCEDURES TABLE 41 GLOBAL FROZEN EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 42 GLOBAL DONOR EGG IVF CYCLE MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 43 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY END USERS, 2014-2020 ($MILLION) TABLE 44 GLOBAL IVF HOSPITALS ENDUSER MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 45 GLOBAL IVF SURGICAL CENTERS ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 46 GLOBAL IVF CLINICAL RESEARCH INSTITUTES ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 47 GLOBAL IVF CLINICS ENDUSERS MARKET BY GEOGRAPHY, 2014-2020 ($MILLION) TABLE 48 GLOBAL IVF DEVICES AND CONSUMABLES MARKET BY GEOGRAPHY, 20142020 ($MILLION) TABLE 49 REGULATORY SCENARIO, NORTH AMERICA TABLE 50 NORTH AMERICA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION) TABLE 51 EUROPE IVF CYCLES IN 2014 TABLE 52 REGULATORY SCENARIO IN MANUFACTURING OF IVF DEVICES IN EUROPE TABLE 53 REGULATORY SCENARIO, EUROPE TABLE 54 EUROPE IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION) TABLE 55 POLICIES BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT TABLE 56 ASIA-PACIFIC IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION) TABLE 57 TYPE OF DATA COMPONENTS AND THEIR REQUIREMENTS TABLE 58 REGULATORY SCENARIO, LAMEA TABLE 59 LAMEA IVF DEVICES AND CONSUMABLES MARKET, BY COMPONENTS, 20142020 ($MILLION) TABLE 60 VITROLIFE AB BUSINESS SNAPSHOT TABLE 61 EMD SERONO, INC BUSINESS SNAPSHOT TABLE 62 IRVINE SCIENTIFIC BUSINESS SNAPSHOT TABLE 63 COOPER SURGICAL, INC. BUSINESS SNAPSHOT TABLE 64 COOK MEDICAL, INC. BUSINESS SNAPSHOT TABLE 65 THERMO FISHER SCIENTIFIC INC. BUSINESS SNAPSHOT TABLE 66 GENEA BIOMEDX BUSINESS SNAPSHOT TABLE 67 AUXOGYN, INC. BUSINESS SNAPSHOT TABLE 68 OXFORD GENE TECHNOLOGY BUSINESS SNAPSHOT TABLE 69 OVASCIENCE, INC. BUSINESS SNAPSHOT
The IVF market analyzed in this report includes the various technologies of in-vitro fertilization along with the instruments, reagents and media used during the procedures. The market is segmented into instruments, reagents and media, technology and end users. This report excludes the in depth analysis of IVF in the service market and drugs market.
The scope of the market in the upcoming years is increase in technological advancement, high success rates, cost efficient treatments, and uncomplicated procedures that would save both the patients as well as the doctor’s time.
This market has growth opportunities in the geographic areas such as Asia pacific and RoW, where the rate of infertility is increasing and need for better IVF techniques that are cost efficient.
This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.
Enzymes have gathered a special attention in the recent years due to its potential application in the several industries such as food & animal feed, textiles and Surfactants, pharmaceuticals & biotechnology R&D and manufacturing and others (paper and pulp processing, leather processing and agriculture).
Capsule endoscopy is a non-invasive technique that allows the complete examination of the gastrointestinal tract using a wireless, disposable device known as a video capsule, which is equipped with a camera, battery, transmitter and a light source.battery, transmitter and a light source. Video capsules capture images in the esophagus, stomach and small intestine, which are utilized for the diagnosis of gastrointestinal diseases.
The COPD and Asthma hold the largest market share within the global respiratory diseases’ market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma globally. COPD was the 3rd leading cause for death with 3 million people in 2013.
Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. These medicines find applicability in wide range of degenerative disorders including dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications. Researchers are engaged in developing technologies based on biologics, genes, somatic as well as stem cells.
Disposable medical devices sensors are handheld or portable scanning devices used for patient monitoring, diagnostics or therapeutics. These devices are used to monitor basic vital signs. One of the widely used sensor device is Scanadu, which is a small hand-held sensor and is positioned on the patients forehead to measure heart rate, breathing rates, blood oxygenation levels, pulse transmit time and temperatures.
Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition
Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinsons disease, Alzheimers disease, and traumatic brain injuries among others
Biosimulation refers to simulation of biological processes by means of computer program. Biosimulation technology has wide application in drug discovery and development. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials. The report provides in-depth analysis of the different segments for global biosimulation market and comprehensively determines the market drivers, major constraints and potential opportunities. Pin-point analysis of leading company profiles and their strategies would be helpful to professionals to gain the competitive intelligence.